Works by Sato, Shinya

Results: 323
    1
    2

    Fibrosis stage is an independent predictor of liver‐related complications in primary biliary cholangitis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 7, p. 968, doi. 10.1111/hepr.14192
    By:
    • Fujinaga, Yukihisa;
    • Namisaki, Tadashi;
    • Tsuji, Yuki;
    • Shibamoto, Akihiko;
    • Kubo, Takahiro;
    • Koizumi, Aritoshi;
    • Matsuda, Takuya;
    • Inoue, Takashi;
    • Iwai, Satoshi;
    • Tomooka, Fumimasa;
    • Tanaka, Misako;
    • Takaya, Hiroaki;
    • Noguchi, Ryuichi;
    • Nishimura, Norihisa;
    • Sato, Shinya;
    • Kitagawa, Koh;
    • Kaji, Kosuke;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Asada, Kiyoshi
    Publication type:
    Article
    3
    4

    A simplified procedure of nerve‐sparing radical hysterectomy.

    Published in:
    Journal of Obstetrics & Gynaecology Research, 2022, v. 48, n. 3, p. 766, doi. 10.1111/jog.15154
    By:
    • Komatsu, Hiroaki;
    • Okawa, Masayo;
    • Hikino, Kohei;
    • Iida, Yuki;
    • Osaku, Daiken;
    • Kudoh, Akiko;
    • Chikumi, Jun;
    • Sato, Shinya;
    • Oishi, Tetsuro;
    • Harada, Tasuku
    Publication type:
    Article
    5
    6
    7
    8

    Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 148, n. 1, p. 17, doi. 10.1007/s11060-020-03505-9
    By:
    • Natsume, Atsushi;
    • Aoki, Kosuke;
    • Ohka, Fumiharu;
    • Maeda, Sachi;
    • Hirano, Masaki;
    • Adilijiang, Alimu;
    • Motomura, Kazuya;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko
    Publication type:
    Article
    9

    JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 627, doi. 10.1007/s11060-018-2831-7
    By:
    • Wakabayashi, Toshihiko;
    • Natsume, Atsushi;
    • Mizusawa, Junki;
    • Katayama, Hiroshi;
    • Fukuda, Haruhiko;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko;
    • Kurisu, Kaoru;
    • Yamasaki, Fumiyuki
    Publication type:
    Article
    10
    11
    12
    13

    Alteration of telomerase activity in ovarian cancer after chemotherapy.

    Published in:
    2000
    By:
    • Takahashi, Masakuni;
    • Kigawa, Junzo;
    • Oishi, Tetsuro;
    • Itamochi, Hiroaki;
    • Shimada, Muneaki;
    • Sato, Shinya;
    • Kamazawa, Shunji;
    • Akeshima, Ryouji;
    • Terakawa, Naoki;
    • Takahashi, M;
    • Kigawa, J;
    • Oishi, T;
    • Itamochi, H;
    • Shimada, M;
    • Sato, S;
    • Kamazawa, S;
    • Akeshima, R;
    • Terakawa, N
    Publication type:
    journal article
    14
    15
    16
    17
    18

    Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3510, doi. 10.3390/jcm9113510
    By:
    • Ishida, Koji;
    • Namisaki, Tadashi;
    • Murata, Koji;
    • Fujimoto, Yuki;
    • Takeda, Souichi;
    • Enomoto, Masahide;
    • Ogawa, Hiroyuki;
    • Takagi, Hirotetsu;
    • Tsuji, Yuki;
    • Kaya, Daisuke;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Sawada, Yasuhiko;
    • Kitagawa, Kou;
    • Sato, Shinya;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Kawaratani, Hideto
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.

    Published in:
    International Journal of Hematology, 2022, v. 116, n. 2, p. 228, doi. 10.1007/s12185-022-03347-3
    By:
    • Miyazaki, Yasushi;
    • Kiguchi, Toru;
    • Sato, Shinya;
    • Usuki, Kensuke;
    • Ishiyama, Ken;
    • Ito, Yoshikazu;
    • Suzuki, Takahiro;
    • Taguchi, Jun;
    • Chiba, Shigeru;
    • Dobashi, Nobuaki;
    • Tomita, Akihiro;
    • Harada, Hironori;
    • Handa, Hiroshi;
    • Horiike, Shigeo;
    • Maeda, Tomoya;
    • Matsuda, Mitsuhiro;
    • Ichikawa, Motoshi;
    • Hata, Tomoko;
    • Honda, Sumihisa;
    • Iyama, Satoshi
    Publication type:
    Article
    35

    Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.

    Published in:
    2020
    By:
    • Kasai, Sachie;
    • Itonaga, Hidehiro;
    • Niino, Daisuke;
    • Miyoshi, Hiroaki;
    • Kato, Takeharu;
    • Imanishi, Daisuke;
    • Fujioka, Machiko;
    • Furumoto, Takafumi;
    • Sato, Shinya;
    • Sawayama, Yasushi;
    • Taguchi, Jun;
    • Imaizumi, Yoshitaka;
    • Hata, Tomoko;
    • Yoshida, Shinichiro;
    • Moriuchi, Yukiyoshi;
    • Ohshima, Koichi;
    • Miyazaki, Yasushi
    Publication type:
    Correction Notice
    36

    Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 524, doi. 10.1007/s12185-020-02926-6
    By:
    • Kasai, Sachie;
    • Itonaga, Hidehiro;
    • Niino, Daisuke;
    • Miyoshi, Hiroaki;
    • Kato, Takeharu;
    • Imanishi, Daisuke;
    • Fujioka, Machiko;
    • Furumoto, Takafumi;
    • Sato, Shinya;
    • Sawayama, Yasushi;
    • Taguchi, Jun;
    • Imaizumi, Yoshitaka;
    • Hata, Tomoko;
    • Yoshida, Shinichiro;
    • Moriuchi, Yukiyoshi;
    • Ohshima, Koichi;
    • Miyazaki, Yasushi
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Erratum to: Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.

    Published in:
    2012
    By:
    • Tominaga-Sato, Shinya;
    • Tsushima, Hideki;
    • Ando, Koji;
    • Itonaga, Hidehiro;
    • Imaizumi, Yoshitaka;
    • Imanishi, Daisuke;
    • Iwanaga, Masako;
    • Taguchi, Jun;
    • Fukushima, Takuya;
    • Yoshida, Shinichiro;
    • Hata, Tomoko;
    • Moriuchi, Yukiyoshi;
    • Kuriyama, Kazutaka;
    • Mano, Hiroyuki;
    • Tomonaga, Masao;
    • Miyazaki, Yasushi
    Publication type:
    Correction Notice
    44

    Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.

    Published in:
    2011
    By:
    • Tominaga-Sato, Shinya;
    • Tsushima, Hideki;
    • Ando, Koji;
    • Itonaga, Hidehiro;
    • Imaizumi, Yoshitaka;
    • Imanishi, Daisuke;
    • Iwanaga, Masako;
    • Taguchi, Jun;
    • Fukushima, Takuya;
    • Yoshida, Shinichiro;
    • Hata, Tomoko;
    • Moriuchi, Yukiyoshi;
    • Kuriyama, Kazutaka;
    • Mano, Hiroyuki;
    • Tomonaga, Masao;
    • Miyazaki, Yasushi
    Publication type:
    journal article
    45
    46
    47
    48
    49

    No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4490, doi. 10.1111/cas.14653
    By:
    • Toriyama, Eo;
    • Hata, Tomoko;
    • Yokota, Ken‐ichi;
    • Chiwata, Masahiko;
    • Kamijo, Rena;
    • Hashimoto, Miki;
    • Taguchi, Masataka;
    • Horai, Makiko;
    • Matsuo, Masatoshi;
    • Matsuo, Emi;
    • Takasaki, Yumi;
    • Kawaguchi, Yasuhisa;
    • Itonaga, Hidehiro;
    • Sato, Shinya;
    • Ando, Koji;
    • Sawayama, Yasushi;
    • Taguchi, Jun;
    • Imaizumi, Yoshitaka;
    • Tsushima, Hideki;
    • Jo, Tatsuro
    Publication type:
    Article
    50

    Using the transgenic rat for adenocarcinoma of prostate (TRAP) model, apocynin, an inhibitor of NADPH oxidase, was shown to suppress prostate carcinogenesis. Representative histopathological finding for lesions in the lateral prostates of TRAP rats treated with 500 mg/L apocynin

    Published in:
    Cancer Science, 2013, v. 104, n. 12, p. 00, doi. 10.1111/cas.12311
    By:
    • Suzuki, Shugo;
    • Shiraga, Kazuhide;
    • Sato, Shinya;
    • Punfa, Wanisa;
    • Naiki‐Ito, Aya;
    • Yamashita, Yoriko;
    • Shirai, Tomoyuki;
    • Takahashi, Satoru
    Publication type:
    Article